Stay updated on Daratumumab & DLI for Relapsed AML Clinical Trial

Sign up to get notified when there's something new on the Daratumumab & DLI for Relapsed AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab & DLI for Relapsed AML Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    A notice about NIH website terminology changes appears above the 403 error page, and the site revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T19:17:06.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page’s footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T20:13:54.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, indicating an access issue that hides the study details. This blocks viewing the core information for the NCT03537599 entry on ClinicalTrials.gov.
    Difference
    20%
    Check dated 2026-09-22T21:51:52.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page now displays revision: v3.7.0, replacing the previous v3.6.6. This indicates a software/template update to the page rather than changes to study data.
    Difference
    0.1%
    Check dated 2026-09-15T21:01:46.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page shows a new revision label, updating from v3.6.5 to v3.6.6, reflecting a minor update to the study details page. No study data or text content changes are indicated.
    Difference
    0.1%
    Check dated 2026-09-01T18:06:32.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5, indicating an administrative update to the page. This reflects an internal release rather than changes to study details or content.
    Difference
    0.1%
    Check dated 2026-08-11T20:39:59.000Z thumbnail image

Stay in the know with updates to Daratumumab & DLI for Relapsed AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab & DLI for Relapsed AML Clinical Trial page.